News Focus
News Focus
Post# of 257285
Next 10
Followers 843
Posts 122810
Boards Moderated 10
Alias Born 09/05/2002

Re: DewDiligence post# 90708

Wednesday, 02/24/2010 11:53:28 PM

Wednesday, February 24, 2010 11:53:28 PM

Post# of 257285
MNTA Insider Shareholdings

[Updated for SEC filings through 2/24/10. The tallies
below include both ordinary and restricted shares
and both vested and non-vested options.]


Executive Officers
*Craig Wheeler, CEO 483,126 shares 675,000 options
G. Venkataraman, SVP R&D 475,475 shares 189,325 options
Steven Brugger, COO 297,183 shares 246,194 options
*John Bishop, SVP Pharma 52,747 shares 192,308 options
Bruce Leicher, Gen Counsel 39,921 shares 137,050 options
James Roach, CMO 19,000 shares 205,250 options
*Richard Shea, CFO 41,686 shares 249,200 options
===== ========= =========
7 Executive Officers 1,409,138 shares 1,894,327 options


Non-executive Directors
John Clarke 77,123 shares 111,000 options
Alan Crane 578,602 shares 88,600 options
Bruce Downey† 0 shares 30,000 options
Marsha Fanucci 0 shares 111,000 options
Peter Hutt 67,863 shares 186,500 options
*Ram Sasisekharan 381,344 shares 111,000 options
*Bennett Shapiro 7,000 shares 125,450 options
Elizabeth Stoner 0 shares 64,200 options
James Sulat‡ 0 shares 45,000 options
===== ========= =======
9 Non-executive Dirctrs 1,111,932 shares 872,750 options


All Officers/Directors 2,521,070 shares 2,767,077 options


*10b5-1 selling plan in effect.
†Joined BoD 6/11/09.
‡Joined BoD 6/5/08.



“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today